You are here:
Research Programs
>
Clinical Research Programs
>
Clinical Trials
>
Phase I study of Tomudex and Gemcitabine
> Application
Phase I study of Tomudex and Gemcitabine
(Protocol 1694-CN/0002)
Online application
Clinical Trial
E-mail
By M.D.
-Name of M.D., hospital centre
-Stage and pathology at diagnosis:
-Surgery-radiation-chemotherapy-
(#of different regiments)
-Last therapy- data, day, dose, schedule
-Performance status
By Patient
Diagnosis
previous Rx
Current condition
You must have a recent medical summary from your doctor sent to us within the week